Autres langues Devyser Diagnostics AB Börse Stuttgart

Actions

OL0

SE0016588867

Recherche biotechnologique et médicale

Marché Fermé - Börse Stuttgart 21:56:31 06/10/2026			Varia. 5j.	Varia. 1 janv.
4,785 ^EUR	+1,16%		+7,05%	-53,18%

16/09	Le PDG de Devyser achète des actions pour 54 000 couronnes	FW
04/09	L'actionnaire principal Arnhult renforce sa participation dans Devyser	FW

Autres langues

31/08	Devyser Diagnostics Names Chief Commercial Officer
31/08	Devyser Diagnostics Announces Appointment of Torben Thölix to Chief Commercial Officer, Effective October 1, 2026
06/08	Devyser, Illumina Land Commercial Reagent Rental Deal in Italy
06/08	Devyser Diagnostics Signs First Commercial Reagent Rental Agreement with Illumina Inc. in Italy
20/07	Devyser Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
16/07	Devyser Diagnostics Announces Launch of One Lambda Devyser Chimerism Plus for Chimerism Analysis Following Allogeneic Hematopoietic Stem Cell Transplantation
14/07	Invitation to audiocast for Devyser’s Q2 report 2026
02/07	Devyser Diagnostics AB Announces Group Preliminary Sales Results for the Second Quarter and First Half of the Year 2026
25/06	Devyser Diagnostics Secures SEK 8.9 Million Five-Year Tender In Italy
05/06	Diamyd Medical Names Interim CFO
22/05	Devyser Diagnostics Appoints New CFO
22/05	Devyser Diagnostics appoints Niklas Axelsson as CFO
22/05	Devyser Announces CFO Changes
06/05	Bulletin from the Annual General Meeting of Devyser Diagnostics AB (publ) held on 6 May 2026
06/05	Devyser Diagnostics AB Announces Isabelle Ducellier's Decision to Decline Re-Election as Members of the Board of Director
27/04	Devyser Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2026
27/04	Devyser Diagnostics AB publishes quarterly report for the period January to March 2026
22/04	Invitation to audiocast for Devyser’s Q1 report 2026
07/04	Devyser announces that Chief Commercial Officer will leave the company
07/04	Devyser Diagnostics Commercial Chief to Exit
07/04	Biovica International Announces CEO Changes
07/04	Devyser Diagnostics AB Announces Departure of Theis Kipling as Chief Commercial Officer
01/04	Sweden's Devyser Closes SEK12 Million Purchase of Cybergene
01/04	Devyser completes Cybergene acquisition, carries out compensation share issue
01/04	Devyser completes acquisition of CyberGene AB and carries out issue of compensation shares